These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1644090)

  • 1. The relationship between diuretic dose, and the haemodynamic response to captopril in patients with cardiac failure.
    Flapan AD; Davies E; Williams BC; Shaw TR; Edwards CR
    Eur Heart J; 1992 Jul; 13(7):971-5. PubMed ID: 1644090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute administration of captopril lowers the natriuretic and diuretic response to a loop diuretic in patients with chronic cardiac failure.
    Flapan AD; Davies E; Waugh C; Williams BC; Shaw TR; Edwards CR
    Eur Heart J; 1991 Aug; 12(8):924-7. PubMed ID: 1915430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of correlation between the acute haemodynamic response to intravenous captopril and plasma concentrations of angiotensin II in patients with chronic cardiac failure.
    Flapan AD; Shaw TR; Edwards CR; Rademaker M; Davies E; Williams BC
    Eur J Clin Pharmacol; 1992; 43(1):1-5. PubMed ID: 1505601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure.
    Mentz RJ; Stevens SR; DeVore AD; Lala A; Vader JM; AbouEzzeddine OF; Khazanie P; Redfield MM; Stevenson LW; O'Connor CM; Goldsmith SR; Bart BA; Anstrom KJ; Hernandez AF; Braunwald E; Felker GM
    JACC Heart Fail; 2015 Feb; 3(2):97-107. PubMed ID: 25543972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posture determines the nature of the interaction between angiotensin converting enzyme inhibitors and loop diuretics in patients with chronic cardiac failure.
    Flapan AD; Davies E; Waugh C; Williams BC; Shaw TR; Edwards CR
    Int J Cardiol; 1991 Dec; 33(3):377-83. PubMed ID: 1761331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptomatic hemodynamic and hormonal effects of intravenous captopril in patients with heart failure.
    Wu H; Zhao HY
    Chin Med J (Engl); 1994 May; 107(5):342-6. PubMed ID: 7924573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemodynamic effects of captopril in acute left ventricular failure complicating myocardial infarction.
    McAlpine HM; Morton JJ; Leckie B; Dargie HJ
    J Cardiovasc Pharmacol; 1987; 9 Suppl 2():S25-30. PubMed ID: 2441196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II levels, hemodynamics, and sympathoadrenal function after low-dose captopril in heart failure.
    Cleland J; Semple P; Hodsman P; Ball S; Ford I; Dargie H
    Am J Med; 1984 Nov; 77(5):880-6. PubMed ID: 6388325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
    Rademaker MT; Charles CJ; Nicholls MG; Richards AM
    Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postural hypotension during tilt with chronic captopril and diuretic therapy of severe congestive heart failure.
    Cody RJ; Franklin KW; Laragh JH
    Am Heart J; 1982 Apr; 103(4 Pt 1):480-4. PubMed ID: 7039281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemodynamic and hormone responses to acute and chronic frusemide therapy in congestive heart failure.
    Ikram H; Chan W; Espiner EA; Nicholls MG
    Clin Sci (Lond); 1980 Dec; 59(6):443-9. PubMed ID: 7002435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The renin angiotensin aldosterone system and frusemide response in congestive heart failure.
    Reed S; Greene P; Ryan T; Cerimele B; Schwertschlag U; Weinberger M; Voelker J
    Br J Clin Pharmacol; 1995 Jan; 39(1):51-7. PubMed ID: 7756099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemodynamic, hormonal, and electrolyte responses to captopril in resistant heart failure.
    Maslowski AH; Ikram H; Nicholls MG; Espiner EA
    Lancet; 1981 Jan; 1(8211):71-4. PubMed ID: 6109121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of low-dose captopril in addition to furosemide and spironolactone in patients with decompensated liver disease during blunted diuresis.
    van Vliet AA; Hackeng WH; Donker AJ; Meuwissen SG
    J Hepatol; 1992 May; 15(1-2):40-7. PubMed ID: 1324274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Furosemide-induced natriuresis is augmented by ultra-low-dose captopril but not by standard doses of captopril in chronic heart failure.
    Motwani JG; Fenwick MK; Morton JJ; Struthers AD
    Circulation; 1992 Aug; 86(2):439-45. PubMed ID: 1638713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute and long-term haemodynamic and neurohumoral response to nisoldipine vs captopril in patients with heart failure: a randomized double-blind study.
    Schofer J; Hobuss M; Aschenberg W; Tews A
    Eur Heart J; 1990 Aug; 11(8):712-21. PubMed ID: 1975780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of captopril in acute and chronic heart failure. Correlations with plasma levels of noradrenaline, renin, and aldosterone.
    Wenting GJ; Man in't veld AJ; Woittiez AJ; Boomsma F; Laird-Meeter K; Simoons ML; Hugenholtz PG; Schalekamp MA
    Br Heart J; 1983 Jan; 49(1):65-76. PubMed ID: 6336940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic and hormonal responses during captopril therapy for heart failure: acute, chronic and withdrawal studies.
    Nicholls MG; Ikram H; Espiner EA; Maslowski AH; Scandrett MS; Penman T
    Am J Cardiol; 1982 Apr; 49(6):1497-501. PubMed ID: 6803564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practical issues when initiating captopril therapy in chronic heart failure. What is the appropriate dose and how long should patients be observed?
    McLay JS; McMurray J; Bridges A; Struthers AD
    Eur Heart J; 1992 Nov; 13(11):1521-7. PubMed ID: 1464341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Determination of the optimal dose of captopril in the treatment of severe cardiac failure by hourly hemodynamic monitoring].
    Allal J; Pornin M; Rossi F; Poupet JY; Bordage JP; Barraine R
    Arch Mal Coeur Vaiss; 1984 Apr; 77(4):458-67. PubMed ID: 6426432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.